Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.1 USD | -0.90% | 0.00% | +7.84% |
Valuation
Fiscal Period: June | 2019 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|
Capitalization 1 | 18.42 | 53.38 | 21.72 | 13.42 | 12.96 | - | - |
Enterprise Value (EV) 1 | 18.42 | 53.38 | 21.72 | 13.42 | 12.96 | 12.96 | 12.96 |
P/E ratio | -2 x | -5.73 x | -2.69 x | -1.55 x | -1.51 x | -0.99 x | -1.93 x |
Yield | - | - | - | - | - | - | - |
Capitalization / Revenue | - | - | - | - | - | - | 4.32 x |
EV / Revenue | - | - | - | - | - | - | 4.32 x |
EV / EBITDA | - | - | - | - | - | - | - |
EV / FCF | - | - | - | - | -2.31 x | -1.49 x | -2.54 x |
FCF Yield | - | - | - | - | -43.2% | -67.1% | -39.4% |
Price to Book | - | - | - | - | - | - | - |
Nbr of stocks (in thousands) | 3,837 | 11,505 | 11,554 | 11,666 | 11,779 | - | - |
Reference price 2 | 4.800 | 4.640 | 1.880 | 1.150 | 1.100 | 1.100 | 1.100 |
Announcement Date | 19-08-23 | 21-10-12 | 22-10-13 | 23-10-13 | - | - | - |
Income Statement Evolution (Annual data)
Fiscal Period: June | 2019 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|
Net sales 1 | - | - | - | - | - | - | 3 |
EBITDA | - | - | - | - | - | - | - |
EBIT 1 | -8.66 | - | - | -8.943 | -8.9 | -15.1 | -8.8 |
Operating Margin | - | - | - | - | - | - | -293.33% |
Earnings before Tax (EBT) 1 | -8.424 | - | - | -8.589 | -8.7 | -14.8 | -8.4 |
Net income 1 | -8.424 | -8.822 | - | -8.589 | -8.7 | -14.8 | -8.4 |
Net margin | - | - | - | - | - | - | -280% |
EPS 2 | -2.400 | -0.8100 | -0.7000 | -0.7400 | -0.7300 | -1.110 | -0.5700 |
Free Cash Flow 1 | - | - | - | - | -5.6 | -8.7 | -5.1 |
FCF margin | - | - | - | - | - | - | -170% |
FCF Conversion (EBITDA) | - | - | - | - | - | - | - |
FCF Conversion (Net income) | - | - | - | - | - | - | - |
Dividend per Share | - | - | - | - | - | - | - |
Announcement Date | 19-08-23 | 21-10-12 | 22-10-13 | 23-10-13 | - | - | - |
Income Statement Evolution (Quarterly data)
Fiscal Period: June | 2022 Q1 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
---|---|---|---|---|---|---|---|---|---|---|
Net sales 1 | - | - | - | - | - | - | - | - | - | - |
EBITDA | - | - | - | - | - | - | - | - | - | - |
EBIT 1 | - | -1.788 | -1.793 | -1.622 | - | - | - | -2.185 | -2.3 | -2.4 |
Operating Margin | - | - | - | - | - | - | - | - | - | - |
Earnings before Tax (EBT) 1 | - | -1.793 | -1.78 | -1.571 | - | - | - | -2.115 | -2.2 | -2.3 |
Net income 1 | -2.613 | -1.793 | -1.78 | -1.571 | - | - | -1.969 | -2.115 | -2.2 | -2.3 |
Net margin | - | - | - | - | - | - | - | - | - | - |
EPS 2 | -0.2300 | -0.1600 | -0.1500 | -0.1400 | -0.1500 | -0.1500 | -0.1700 | -0.1800 | -0.1900 | -0.2000 |
Dividend per Share | - | - | - | - | - | - | - | - | - | - |
Announcement Date | 21-11-15 | 22-05-16 | 22-10-13 | 22-11-14 | 23-02-14 | 23-05-15 | 23-11-14 | 24-02-14 | - | - |
Balance Sheet Analysis
Fiscal Period: June | 2019 | 2021 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|
Net Debt | - | - | - | - | - | - |
Net Cash position | - | - | - | - | - | - |
Leverage (Debt/EBITDA) | - | - | - | - | - | - |
Free Cash Flow 1 | - | - | - | -5.6 | -8.7 | -5.1 |
ROE (net income / shareholders' equity) | - | - | - | - | - | - |
ROA (Net income/ Total Assets) | - | - | - | - | - | - |
Assets 1 | - | - | - | - | - | - |
Book Value Per Share | - | - | - | - | - | - |
Cash Flow per Share | - | - | - | - | - | - |
Capex 1 | - | - | - | - | - | - |
Capex / Sales | - | - | - | - | - | - |
Announcement Date | 19-08-23 | 21-10-12 | 23-10-13 | - | - | - |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+7.84% | 12.96M | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.74B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- NNVC Stock
- Financials NanoViricides, Inc.